Alexandre Gama has an impressive history in the field of communications and advertising. With his current company Neogama being named as one of the leading advertising companies in Brazil, it is little wonder how this man obtained the notoriety he has in the field of advertising. Alexandre Gama started on his career path by attending Fundacao Armando Alvares Penteado, where he studied advertising. After graduating he landed a job with Standard Ogilvy, where he came up with creative written content.
Although Alexandre Gama rose steadily through the ranks in the advertising industry by working for various agencies, his creative work remained a constant source of recognition by others in the field. Mr. Gama received his first award for writing while employed at a company called DM9, just eight short years after leaving school. Over the years Alexandre Gama’s work has earned him awards from Cannes, the APP and the Communication Agency of Entrepreneurs.
Millions of lives will see improvement due to a recent decision made by the Cancer Treatment Center of America. With the cooperation and resources of Allscripts and Nanthealth, the Cancer Treatment Center has found a way to simplify the lives of not only physicians but individual patients. This collaboration includes the access of clinical workflow in the Allscripts Sunrise electronic health record by, eviti, a clinical support solution produced by Nanthealth. This new solution is termed “Clinical Pathways” and includes the input of hundreds of physicians throughout the nation as well as a complete collection of evolving oncology data. Thus, Clinical Pathways has been a product of much forethought from the brains of the highly intellectual throughout the United States. This new creation potentially eliminates time and error, crucial factors in the oncology field. Although there is a need for verified success, Clinical Pathways has potential to be a catalyst for making a positive difference in the field of oncology. Listed are a few benefits of the intervention: improvement of quality and efficiency of patient care; increased patient confidence of treatment plan; increased insurance approval due to accuracy of clinical data. Clinical Pathways has potential to be an astute evolution of scientific technology.
Unique to other hospitals, The Cancer Treatment Centers of America take an individual- centered approach to the treatment of cancer. As stated on the website it is the CTCA philosophy that “the cancer is as unique as the person fighting it.” Thus, the multidisciplinary team employed at CTCA are solely focused on oncology and evidence- based intervention for the treatment of cancer.
Because CTCA has a philosophy of individual treatment the patient is the focus of the CTCA treatment plan. This includes emphasis on particular patient needs and access of a team of highly qualified individuals to meet those needs.
Paul Mampilly is an American investor who is the winner of the prestigious foundation of Templeton investment competition. He is also the founder of newsletter Profits Unlimited where he uses his skills and experience to guide more than 40,000 subscribers into stocked.
He joined the Sovereign Society in 2016 and serves as a senior editor in technology, small camp stocks, and special opportunities. Starting in the 1980s, he worked as an analyst at Deutsche Asset Management before becoming a money manager for the like of Royal Bank of Scotland. When he was of age 42, he left the Wall Street to become a full-time writer because he wanted to spend more time with his family.
In 2009-2010, he gave $25 billion hedge fund to Kinetics International Fund that posted returns of 67% and 20% in those years. He however directed investments for the Templeton Foundation many times.
Paul Mampilly’s Ideas
Paul has very clear ideas about success and hard work and he wants to help the people by making their minds help them. He says that you can get anything even from the deepest valley of your demise. He believes that their lives will be revolutionized by the technologies and this revolution will generate huge investment opportunities for making money. He wants to give a big platform to invest in the business and to earn more as you can.
Paul is the professional investor who especially worked on Wall Street for more than 20 years and he got his start in the early 1990s and quickly grasped the ladder to reach the peak point of success.
Paul Mampilly is the man of strong will and sense who got success by his words and hard work and achieved the target what he aimed at.